StageZero Life Sciences Ltd. SZLSF
0.00 USD 0.00 (+0.00%)
At closeNov 3, 2026, 4:00 PM EST
0.0117 Day range 0.0117
0.0005 52-week range 0.0117
- YTD
- +100.00%
- 1 year
- -80.39%
- Market cap
- 123.53K
- EPS (ttm)
- -0.04
- YTD return
- +100.00%
- 1-year return
- -80.39%
- Volume
- 300
- Open
- 0.0117
- Previous close
- 0.001
- Day's range
- 0.0117 – 0.0117
- 52-week range
- 0.0005 – 0.0117
2Y -0.0785 (-98.74%)
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Dec 16, 2024 | Sep 1, 2024 | 0.00 | 0.00 | — | — |
| Sep 30, 2024 | Jun 1, 2024 | 0.00 | 0.00 | — | — |
| May 15, 2024 | Mar 1, 2024 | 0.00 | 0.00 | — | — |
| Nov 14, 2023 | Sep 1, 2023 | 0.00 | -0.01 | — | — |
| Aug 14, 2023 | Jun 1, 2023 | 0.00 | 0.00 | — | — |
News
Financial Survey: Stagezero Life Sciences (OTCMKTS:SZLSF) and Envista (NYSE:NVST) 
Fonar (NASDAQ:FONR) and Stagezero Life Sciences (OTCMKTS:SZLSF) Head-To-Head Comparison 
Head-To-Head Review: Insulet (NASDAQ:PODD) and Stagezero Life Sciences (OTCMKTS:SZLSF) 
Contrasting Stagezero Life Sciences (OTCMKTS:SZLSF) and TriSalus Life Sciences (NASDAQ:TLSI) 
StageZero Life Sciences and ElevationMD Introduce Aristotle and AVRT for the Early Detection of Cancer 
StageZero Life Sciences Announces Update on Filing of Full Year 2023 Financials Under the Failure To File Cease Trade Order 
StageZero Life Sciences Announces Update on Filing of Full Year 2023 Financials under the Failure to File Cease Trade Order 
StageZero Life Sciences Ltd. (SZLSF) Q1 2024 Earnings Call Transcript 
StageZero Life Sciences, Ltd Announces Q1 2024 Financial Results and Operational Update 
StageZero Life Sciences Provides an Update on Application for Management Cease Trade Order
Your note
Sign in to keep a note on SZLSF — it syncs with the Stock Master app.